Pathfinder Cell Therapy Stock Probability of Future Pink Sheet Price Finishing Under 1.0E-4

PFND Stock  USD 0.0001  0.00  0.00%   
Pathfinder Cell's future price is the expected price of Pathfinder Cell instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Pathfinder Cell Therapy performance during a given time horizon utilizing its historical volatility. Check out Pathfinder Cell Backtesting, Pathfinder Cell Valuation, Pathfinder Cell Correlation, Pathfinder Cell Hype Analysis, Pathfinder Cell Volatility, Pathfinder Cell History as well as Pathfinder Cell Performance.
  
Please specify Pathfinder Cell's target price for which you would like Pathfinder Cell odds to be computed.

Pathfinder Cell Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pathfinder Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pathfinder Cell Therapy can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pathfinder Cell generated a negative expected return over the last 90 days
Pathfinder Cell has some characteristics of a very speculative penny stock
Net Loss for the year was (1.39 M) with profit before overhead, payroll, taxes, and interest of 0.
Pathfinder Cell Therapy currently holds about 4 K in cash with (963 K) of positive cash flow from operations.

Pathfinder Cell Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pathfinder Pink Sheet often depends not only on the future outlook of the current and potential Pathfinder Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pathfinder Cell's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding667.2 M
Short Long Term DebtM
Cash And Short Term Investments26 K

Pathfinder Cell Technical Analysis

Pathfinder Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Pathfinder Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pathfinder Cell Therapy. In general, you should focus on analyzing Pathfinder Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Pathfinder Cell Predictive Forecast Models

Pathfinder Cell's time-series forecasting models is one of many Pathfinder Cell's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pathfinder Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Pathfinder Cell Therapy

Checking the ongoing alerts about Pathfinder Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pathfinder Cell Therapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pathfinder Cell generated a negative expected return over the last 90 days
Pathfinder Cell has some characteristics of a very speculative penny stock
Net Loss for the year was (1.39 M) with profit before overhead, payroll, taxes, and interest of 0.
Pathfinder Cell Therapy currently holds about 4 K in cash with (963 K) of positive cash flow from operations.

Other Information on Investing in Pathfinder Pink Sheet

Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.